KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,194,200 | -39.4% | 301,741 | +0.2% | 0.00% | -50.0% |
| Q2 2023 | $6,922,335 | -21.7% | 301,102 | +0.9% | 0.00% | -33.3% |
| Q1 2023 | $8,844,466 | +18.9% | 298,497 | +0.2% | 0.00% | +50.0% |
| Q4 2022 | $7,435,784 | +22.6% | 297,908 | +6.9% | 0.00% | 0.0% |
| Q3 2022 | $6,065,000 | +20.1% | 278,560 | +8.6% | 0.00% | 0.0% |
| Q2 2022 | $5,052,000 | -53.2% | 256,542 | +0.5% | 0.00% | -33.3% |
| Q1 2022 | $10,804,000 | -31.5% | 255,277 | +2.7% | 0.00% | -40.0% |
| Q4 2021 | $15,780,000 | +10.4% | 248,534 | +2.2% | 0.01% | 0.0% |
| Q3 2021 | $14,288,000 | +183.0% | 243,225 | +133.7% | 0.01% | +150.0% |
| Q2 2021 | $5,048,000 | +108.0% | 104,076 | +66.7% | 0.00% | +100.0% |
| Q1 2021 | $2,427,000 | -36.2% | 62,448 | +1.8% | 0.00% | -50.0% |
| Q4 2020 | $3,803,000 | – | 61,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |